Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: Differences between Cognitive Subtypes by Cerff B et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License 
 
 
Newcastle University ePrints - eprint.ncl.ac.uk 
 
Cerff B, Maetzler W, Sulzer P, Kampmeyer M, Prinzen J, Hobert MA, Blum D, 
van Lummel R, Del Din S, Graeber S, Berg D, Liepelt-Scarfone I. 
Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: 
Differences between Cognitive Subtypes. 
Neurodegenerative Diseases 2017, 17(4-5), 135-144 
 
Copyright: 
This is the peer-reviewed but unedited manuscript version of the following article: Cerff B, Maetzler W, 
Sulzer P, Kampmeyer M, Prinzen J, Hobert MA, Blum D, van Lummel R, Del Din S, Graeber S, Berg D, 
Liepelt-Scarfone I. Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: 
Differences between Cognitive Subtypes. Neurodegenerative Diseases 2017, 17(4-5), 135-144. The final, 
published version is available at http://www.karger.com/10.1159/000460251 
DOI link to article: 
https://doi.org/10.1159/000460251 
Date deposited:   
03/05/2017 
Embargo release date: 
26 April 2018  
1 
 
Home-based physical behavior in late stage 1 
Parkinson´s disease dementia: differences 2 
between cognitive subtypes 3 
Bernhard Cerff1,2, Walter Maetzler, MD2,4, Patricia Sulzer1,2, Malte Kampmeyer1,2, 4 
Jos Prinzen, BEng5, Markus A. Hobert2,4, Dominik Blum, MSc1,2,3, Rob van 5 
Lummel, MSc5, Silvia Del Din, PhD6, Susanne Gräber, PhD1,2, Daniela Berg, 6 
MD2,4, Inga Liepelt-Scarfone*, PhD1,2 7 
 8 
1German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, 9 
Tübingen, Germany, inga.liepelt@dzne.de, bernhard.cerff@student.uni-10 
tuebingen.de, Patricia.Sulzer@med.uni-tuebingen.de, 11 
maltekampmeyer@hotmail.de, dominik.blum@med.uni-tuebingen.de, 12 
susanne.graeber-sultan@uni-tuebingen.de 13 
2Hertie Institute for Clinical Brain Research, Department of Neurodegenerative 14 
Diseases, University of Tübingen, Tübingen, Germany 15 
3 Department of Nuclear Medicine and Clinical Molecular Imaging, University of 16 
Tübingen, Germany 17 
4Department of Neurology, Christian-Albrechts-University, Kiel, Germany, 18 
w.maetzler@neurologie.uni-kiel.de, Markus.Hobert@uksh.de, 19 
Daniela.Berg@uksh.de 20 
5McRoberts B.V., The Hague, The Netherlands, J.Prinzen@mcroberts.nl, 21 
rcvanlummel@mcroberts.nl 22 
6Institute of Neuroscience/ Newcastle University Institute for Ageing, Clinical 23 
Ageing Research Unit, Campus for Ageing and Vitality, Newcastle University, 24 
Newcastle upon Tyne, UK, silvia.del-din@newcastle.ac.uk 25 
Word count abstract/ main text: 248/3033 26 
Number of tables/figures: 2/3 27 
Number of supplementary tables/figures: 1/1 28 
Correspondence to:  29 
Inga Liepelt-Scarfone, PhD 30 
German Center of Neurodegenerative Diseases and Hertie Institute for Clinical 31 
Brain Research  32 
Department of Neurodegeneration 33 
Hoppe-Seyler Str. 3 34 
D-72076 Tuebingen, Germany 35 
Tel: +4970712080424 36 
Fax: +49707294490 37 
E-Mail: inga.liepelt@dzne.de  38 
2 
 
Abstract 1 
Background: For the early diagnosis of Parkinson’s disease dementia 2 
(PDD), objective home-based tools are needed to quantify even mild 3 
stages of activities of daily living (ADL) dysfunction.  4 
Objectives: In this pilot study, home-based physical behavior was assessed 5 
to examine whether it is possible to distinguish mild cognitive impairment 6 
(PD-MCI) from PDD. 7 
Methods: Fifty five patients with mild to severe Parkinson´s disease (PD) 8 
participated in this cross-sectional study. Based on comprehensive 9 
neuropsychological testing, PD patients were classified as cognitively non-10 
impaired (PD-NC), PD-MCI or PDD. For physical behavior assessments, 11 
patients wore the accelerometer DynaPort® (McRoberts) for three days. 12 
Ordinal logistic regression models with continuous Y were applied to 13 
correct results for motor impairment and depressive symptoms. 14 
Results: After excluding 7 patients due to insufficient wearing time, 48 15 
patients with a mean of 2 recorded days were analyzed (17 PD-NC, 22 PD-16 
MCI, 9 PDD). ADL-impaired PDD patients showed fewer sedentary bouts 17 
than non- ADL-impaired PD-MCI [P=0.01 odds ratio (OR)=8.9, 95% 18 
confidence interval (CI)=1.8-45.2] and PD-NC (P=0.01, OR=10.3, CI=1.6-19 
67.3) patients, as well as a longer sedentary bout length (PD-NC: P=0.02, 20 
OR=0.1, CI=0.02-0.65; PD-MCI: P=0.02, OR=0.14, CI=0.03-0.69). These 21 
differences were mainly caused by fewer (PD-NC: P=0.02, OR=9.6, 22 
CI=1.5-62.4; PD-MCI: P=0.01, OR=8.5, CI=1.5-37.3), but longer sitting 23 
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bouts (PD-NC: P=0.03, OR=0.12, CI=0.02-0.80; PD-MCI: P=0.04, 1 
OR=0.19, CI=0.04-0.93). Tests assessing executive function, visuo-2 
construction and attention correlated significantly with specific activity 3 
parameters (rho≥0.3; P<0.05). 4 
Conclusion: Objective assessment of physical behavior, in particular the 5 
detection of sedentary bouts, is a promising contributor to the 6 
discrimination between PD-MCI and PDD.  7 
Key words: Parkinson's disease; Dementia; Physical activity; Activities of 8 
daily living; Cognition; Accelerometer; Sedentary behavior.  9 
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1. Background 1 
Dementia is common in Parkinson´s disease (PD) [1,2], and objective tools 2 
allowing for the assessment of activities of daily living (ADL) function, and 3 
thereby an early diagnosis of Parkinson´s disease dementia (PDD), are 4 
needed, especially as effective therapeutic options are available [3]. 5 
With the development of wearable and relatively unobtrusive sensor 6 
systems during recent years, it has become feasible to assess home-based 7 
physical behavior of PD patients over longer time periods[4], and thus 8 
indirectly monitor ADL function [5,6]. Since ADL function is essential for the 9 
discrimination of PDD from mild cognitive impairment (PD-MCI) patients 10 
[7,8], its unbiased assessment is of utmost importance. 11 
It is known that both dementia and PD are associated with reduced 12 
physical activity, which can be seen even years before the diagnosis can 13 
be made [9–12], yet there are few studies that investigate advanced 14 
disease stages. Those few studies indicate that late stage PD patients 15 
show longer bouts of sedentary behavior [13], and that energy expenditure 16 
is related to cognition [14]. However, these studies excluded patients with 17 
more advanced cognitive impairment [13,14]. To the best of our knowledge, 18 
no study is currently available that has objectively assessed 19 
comprehensive physical behavior parameters of PD patients with advanced 20 
cognitive impairment or PDD. 21 
The aim of this pilot study was to test whether objectively assessed 22 
physical behavior parameters could contribute to the discrimination of 23 
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cognitive subtypes of PD, especially between PDD and mild cognitive 1 
impairment (PD-MCI). 2 
2. Methods 3 
2.1 Participants 4 
A total of 55 PD patients were investigated within the frame of the 5 
Dempark/Landscape study [15]. Diagnosis of PD was made according to 6 
the adapted United Kingdom Parkinson´s Disease Society Brain Bank 7 
Criteria. Inclusion criteria included: age between 45 and 80 years, German 8 
as a first language, and adequate or corrected hearing/visual abilities. The 9 
following exclusion criteria were applied: history of other neurological 10 
diseases affecting the central nervous system, onset of dementia within 11 
one year after PD diagnosis, prior surgery due to PD, and a Mini-Mental 12 
State Examination (MMSE) [16] score < 18 points (a required cut-off, as 13 
only individuals with the capacity to give informed consent could be 14 
included). 15 
The study was approved by the local ethical committee. All participants 16 
gave written informed consent.  17 
2.2 Cognitive and motor examination 18 
Each individual underwent a clinical assessment that included the Unified 19 
Parkinson Disease Rating Scale part III (UPDRS III) [17], and the Hoehn & 20 
Yahr staging scores [18]. Demographical data and medication intake was 21 
also assessed. Intake of dopamimetics is expressed as the levodopa 22 
equivalent daily dose (LEDD) [19]. All participants underwent a 23 
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comprehensive neuropsychological assessment that included the MMSE, 1 
the Parkinson Neuropsychometric Dementia Assessment (PANDA) [20], 2 
and the Geriatric Depression Scale (GDS) [21], among others. Details are 3 
provided in Table 1 and in the supplementary Table A. 4 
Three groups were classified according to the criteria listed below: non-5 
cognitively impaired (PD-NC), for patients not meeting criteria of other 6 
cognitive subtypes, PD-MCI, and PDD. 7 
PD-MCI was diagnosed when the following criteria were met: (i.) one or 8 
more test scores ≥1.5 standard deviations below published group 9 
normative values of healthy control subjects in at least one of the following 10 
cognitive domains: attention, executive functions, visuo-spatial function, 11 
memory, or language ability; (ii.) no significant impairment of ADL reported 12 
by either the patient or the proxy; (iii.) no other primary explanations for 13 
cognitive impairment or PD-associated symptoms that could significantly 14 
influence cognitive testing. 15 
Diagnostic criteria for PDD followed the Level-II recommendation of the 16 
MDS Task Force for probable PDD [7]: (i.) At least one score ≥1.5 standard 17 
deviations below published group normative values of healthy control 18 
subjects in at least two of the aforementioned five cognitive domains; (ii.) 19 
impairment of ADL and cognitive decline with insidious onset and slow 20 
progression reported by either the patient or the proxy. Details about the 21 
neuropsychological assessment are provided in supplementary Table A. 22 
2.3 Objective physical behavior assessment and parameters 23 
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All participants were asked to wear the triaxial accelerometer DynaPort 1 
Minimod® sensor (McRoberts, The Netherlands; dimensions: 64 x 62 x 13 2 
mm) on their lower back for three consecutive days. Data was collected 3 
with a sample frequency of 100 Hz and a resolution of 1 milli g-force (mg), 4 
and then stored on a secure digital memory card inside the device [22]. 5 
Participants were asked to keep a logbook during the measurement. The 6 
following time periods were documented: taking the device off (for water-7 
associated tasks), sleeping, out-of-house activities and special occasions. 8 
The logbook was used for plausibility analysis in the case of irregular 9 
measurements. Raw data was analyzed with algorithms provided by 10 
McRoberts. 11 
These algorithms differentiated the following behaviors: lying, sitting, 12 
standing, walking, and shuffling (defined as an activity in upright position 13 
performed with a locomotion-specific intensity, but without a locomotion-14 
specific horizontal acceleration signal) [23,24]. Behaviors were also 15 
combined for better interpretation: (i.) sedentary combines lying and sitting; 16 
(ii.) activity combines standing, shuffling and walking. Moreover, steps 17 
taken during shuffling and walking were identified. Time in which the sensor 18 
was not worn by the participant was detected (not-wearing time). Various 19 
parameters were identified and calculated, according to the criteria listed in 20 
the following sections.  21 
2.3.1 Volume 22 
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Volume was defined by (i.) amount of total time spent in each behavior 1 
(e.g. lying time), normalized as a percentage of 24 hours; (ii.) total number 2 
of steps per day; (iii.) total amount of time spent in each intensity level 3 
(defined using threshold on Metabolic Equivalent of Task category, MET) 4 
normalized as a percentage of 24 hours: sedentary activity, ≤ 1.5 METs; 5 
light activity, 1.5 < x < 3 METs; moderate activity, 3 ≤ x < 6 METs; vigorous 6 
activity, ≥ 6 METs. 7 
2.3.2 Pattern 8 
Patterns were defined according to (i.) total number of bouts per day for 9 
each behavior (e.g. number of lying bouts); (ii.) mean bout length for each 10 
behavior per day (e.g. mean lying bout length), where a bout, similar to 11 
other studies [13,25], is defined as any period of time spent in a certain 12 
behavior. 13 
2.3.3 Intensity  14 
Intensity, as the mean vector magnitude of dynamic acceleration per day 15 
for each behavior (e.g. lying intensity) or in total (total movement intensity), 16 
was detected and expressed relative to gravitational acceleration by the 17 
unit g (m/s2). 18 
2.3.4 Energy expenditure 19 
Energy expenditure was calculated using an algorithm based on a 20 
validation study with indirect calorimetry [26] and demographic 21 
characteristics of the participants. The following energy expenditure 22 
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parameters were calculated: (i.) Activity related Energy Expenditure per 1 
day (AEE); (ii.) Total Energy Expenditure per day (TEE); (iii.) Physical 2 
Activity Level per day, as the relative energy expenditure to basal metabolic 3 
rate (PAL); (iv.) Physical Activity Ratio, as the relative energy expenditure 4 
to basal metabolic rate for each behavior (PAR) (e.g. PAR of lying). 5 
2.4 Data processing 6 
Criteria for data processing were as follows: days with less than 24 hours 7 
recorded or with a relative wearing time <80% of 24 hours were excluded. 8 
Since no imputation [27] was applied, all results exclude the not-wearing 9 
time. 10 
2.5 Statistical Analysis 11 
Values are reported as median and range. For demographical and clinical 12 
variables, Kruskal-Wallis Test or Chi-square statistics were used. To adjust 13 
the physical behavior parameter outcomes for motor disability and 14 
depressive symptoms, ordinal logistic regression models for continuous Y 15 
[28] were applied. Each physical behavior parameter was chosen as the 16 
dependent variable, whereas group membership (coded as a dummy 17 
variable) and co-variates were included as independent variables, to 18 
correct for the confounders GDS and the UPDRS III score (see Table 1 for 19 
details). The odds ratio (OR) with its confidence interval of 95% (CI) was 20 
used for effect size estimation. The Spearman rho coefficient (rho) was 21 
applied for correlation analysis. An alpha level below 0.05 was considered 22 
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statistically significant. Statistical analyses were performed using SPSS 1 
Statistics 22 (IBM, 2011). 2 
3. Results 3 
Seven subjects were excluded from the analysis. Of these, three were 4 
excluded due to uncompleted days recorded (2 PD-NC, 1 PDD), and four 5 
due to daily wearing time <80% (2 PD-NC, 1 PD-MCI, 1 PDD). After 6 
exclusion of incomplete recorded days, recordings with a mean of 2 7 
complete days (range 1-4) of 48 PD patients (PD-NC, n=17, 35%; PD-MCI, 8 
n=22, 46%; PDD, n=9, 19%) were analyzed. 9 
The UPDRS III and the GDS scores differed significantly between the 10 
cognitive subtypes (PD-NC < PD-MCI < PDD, Table 1). The ordinal logistic 11 
regression model was therefore corrected for these confounders. The 12 
registered not-wearing time (median = 4, range 0 – 280 minutes) did not 13 
differ significantly between the cognitive subgroups. 14 
----Please insert Figure 1-3 near here----- 15 
3.1 Physical behavior outcomes 16 
In both PD-NC and PD-MCI groups, the largest proportion of the day was 17 
spent lying (PD-NC: 37%, PD-MCI: 42%), followed by sitting (PD-NC: 36%, 18 
PD-MCI: 34%), standing (both 14%), walking (PD-NC: 5%, PD-MCI: 4%), 19 
shuffling (PD-NC: 2%, PD-MCI: 1%), and not-wearing (<1%). In the PDD 20 
group, the most frequent behavior was sitting (42%), followed by lying 21 
(40%) (Figure 1). 22 
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Descriptively, median values for active physical behavior were relatively 1 
low in in the PDD group, but no significant difference in relation to the other 2 
cognitive groups was found (P > 0.05, Figure 2 and Table 2). Median 3 
activity time was 9% in the PDD group, compared to 21% in both PD-MCI 4 
and PD-NC groups (P> 0.05, Table 2). In contrast, median sedentary time 5 
was 89% for PDD, 78% for PD-MCI, and 75% for PD-NC (P > 0.05, Figure 6 
2). 7 
Walking time was 1.8% in PDD, 3.9% in PD-MCI (P=0.67, OR= 1.40, CI= 8 
0.30-6.46), and 5.2% in the PD-NC group (P=0.44, OR= 2.01, CI=0.34-9 
12.03). Patients with PDD had a median number of 2362 steps, patients 10 
with PD-MCI 4742 steps (P= 0.72, OR=1.33, CI= 0.29-6.11), and patients 11 
with PD-NC 5778 steps (P= 0.48, OR= 1.91, CI=0.32-11.42, Figure 2). 12 
The PDD group had a tendency to show low values, however, differences 13 
in intensity and energy expenditure parameters were not statistically 14 
significant between the groups (P > 0.05, Table 2). Similarly, time spent in 15 
different MET-categories was comparable between the study groups (P > 16 
0.05, Table 2). 17 
The groups deviated in the pattern of sedentary behavior (Figure 3). The 18 
parameter mean sedentary bout length was significantly longer in PDD 19 
(727 s) than in both PD-MCI (515 s, P= 0.02, OR= 0.14, CI= 0.03-0.69) and 20 
PD-NC (506 s, P=0.02, OR=0.1, CI=0.02-0.65, Figure 3D). Moreover, the 21 
PDD group had a reduced number of sedentary bouts (97) compared to the 22 
PD-MCI (129, P= 0.01, OR= 8.9, CI= 1.8-45.2) and PD-NC groups (134, P= 23 
0.01, OR= 10.3, CI= 1.6-67.3, Figure 3C). These differences were mainly 24 
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caused by fewer, but longer bouts of sitting behavior from the PDD group 1 
(P< 0.05, Figure 3E and 3F). 2 
3.2 Correlation of sitting parameters with parameters of other 3 
behaviors 4 
An increase of sitting time correlated significantly with a longer lying time 5 
(rho = 0.55, P < 0.01, supplementary Figure A) but not with the ‘time’ 6 
parameter of other behaviors (rho ≤ 0.19, P > 0.05). A higher sitting 7 
intensity correlated with a higher sedentary intensity (rho = 0.84, P < 0.01) 8 
and a higher standing intensity (rho = 0.36, P < 0.05), but not with the 9 
‘intensity’ parameter of other behaviors (rho ≤ 0.19, P > 0.05). An increase 10 
in the number of sitting bouts correlated with a higher number of bouts of all 11 
other behaviors (rho ≥ 0.65, P < 0.01), except for the number of lying bouts 12 
(rho = -0.13, P > 0.05). An increase in mean sitting bout length was 13 
associated with higher ‘mean bout length‘ of both sedentary behavior and 14 
shuffling behavior (rho ≥ 0.39, P < 0.01), but not with higher ‘mean bout 15 
length‘ of other behaviors (rho ≤ 0.14, P > 0.05). 16 
For the behaviors standing, shuffling, walking, and activity, higher values of 17 
the registered ‘time‘, ‘intensity‘, and ‘number of bouts‘ parameters 18 
correlated significantly with each other (rho = 0.34 to rho = 1, P < 0.05). 19 
Standing mean bout length only correlated with mean walking bout length 20 
(rho = -0.31, P < 0.05) and mean activity bout length (rho = 0.87, P < 0.01, 21 
supplementary Figure A). 22 
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3.3 Correlation of physical behavior outcomes and cognitive 1 
tests 2 
Lower scores of cognitive tests assessing visuo-construction (e.g. the 3 
praxis subtest of the Consortium to establish a registry for Alzheimer’s 4 
disease (CERAD), as well as the mental rotation and spatial sense 5 
subtests of the Leistungsprüfsystem 50+) were associated (P < 0.05) with 6 
the following physical behavior parameters (see supplementary Table A for 7 
details): less moderate activity (rho = 0.31 to 0.47), less light activity (rho = 8 
0.30), fewer steps (rho = 0.32), lower total movement intensity (rho = 0.35), 9 
lower number of activity bouts (rho = 0.31), longer mean activity bout length 10 
(rho = -0.30), more sedentary activity (rho = -0.36), and lower number of 11 
sedentary bouts (rho = 0.32). More impaired attention performance, 12 
represented by at least one of the Stroop-test sub scores, word naming or 13 
color naming, correlated significantly with longer mean activity bout length 14 
(rho = -0.34), less moderate activity (rho = 0.34), lower total movement 15 
intensity (rho = 0.30 to 0.34), and more sedentary activity (rho = -0.33, 16 
supplementary Table A). Decreased performance on the Trail making test 17 
A/B, assessing executive function, was associated with less moderate 18 
activity (rho = 0.31) and a lower number of activity bouts (rho = 0.30). 19 
Reduced phonematic verbal fluency correlated with shorter sedentary time 20 
(rho = 0.30). Worse memory performance (e.g. word-list recall) was 21 
associated with higher activity intensity (rho = -0.31) and a higher number 22 
of steps (rho = -0.30). 23 
14 
 
4. Discussion 1 
In this pilot study, PDD patients showed a tendency for low median values 2 
of active and intensive physical behavior parameters and high median 3 
values for sedentary parameters. These differences were not significant in 4 
the statistical model applied to adjust for depressive symptoms and motor 5 
impairment. However, statistically significant differences with relatively high 6 
effect sizes were observed in the pattern of sedentary physical behavior: 7 
PDD patients had fewer, but longer sedentary bouts than both participants 8 
with PD-NC and PD-MCI. 9 
The dominant role of sedentary behavior is further supported by two 10 
interesting observations of this study. First, unlike the other cognitive 11 
subgroups, the most frequent behavior of the PDD group was sitting. 12 
Second, the results of the correlation analysis showed that most of the 13 
sitting behavior parameters were relatively poorly associated with the 14 
parameters of other behaviors. These results could indicate a special role 15 
of sedentary, especially sitting, parameters among all physical behavior 16 
parameters assessed in our study. 17 
To the best of our knowledge, this is the first study to explore the physical 18 
behavior profile of cognitive subtypes in PD. Dontje and colleagues [14] 19 
reported that 586 PD patients showed a relevant but weak correlation 20 
between MMSE score and energy expenditure using actigraphy. Though 21 
our study did not reproduce this finding with statistical significance, 22 
descriptive values support their findings. The lack of statistical power could 23 
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be due to the relatively small PDD cohort or its relatively large 1 
heterogeneity.  2 
Our findings do however support the reports of Chastin and colleagues 3 
[13], who showed that late stage PD patients had longer sedentary bout 4 
lengths. Moreover, Chen and colleagues [5] compared ADL scores, 5 
assessed by the Tokyo Metropolitan Institute of Gerontology Index of 6 
Competence, with accelerometer data of 1634 older adults. They found a 7 
relevant association between ADL disability and greater volume of 8 
sedentary behavior, as well as a lower number of sedentary bouts. Taking 9 
our findings and the results of the aforementioned studies into account, the 10 
hypothesis that alterations in the sedentary physical behavior pattern, 11 
specifically fewer but longer sedentary bouts, could be associated with ADL 12 
impairment in PD, seems possible. 13 
In accordance with previous study results [29–34], our data confirmed that 14 
less active physical behavior correlated with lower scores on tests 15 
assessing visuo-construction, attention and executive functions, but not 16 
verbal fluency, memory and language performance. This indicates that the 17 
physical behavior profile can, at least partly, reflect cognitive worsening 18 
associated with the domains mentioned above. Linking memory function 19 
with physical behavior is controversial, as only one study so far has 20 
identified a significant correlation [31]. Therefore, more studies are needed 21 
to investigate the relation between cognition and physical behavior in older 22 
adults and in dementia. 23 
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Limitations of this study were: first, sample size and heterogeneity of the 1 
PDD group limited the generalization of our results. Second, no statistical 2 
correction for multiple testing was applied. To reduce the influence of these 3 
limitations, we used non parametric testing.  4 
As can be seen in the scatter dot plots, there may be subgroups that 5 
specifically drive group differences. Further analysis of these outliers 6 
revealed a very heterogenic picture of both participants with only a few 7 
extreme values (≤ 4 parameters: 56% of participants), and participants with 8 
several extreme values (≥ 4 parameters: 23% of participants). The latter 9 
group could be further categorized into participants with very active 10 
physical behavior (10%), participants with very sedentary behavior (8%), 11 
and participants with very few bouts (4%). Therefore, the exclusion of 12 
outliers with an arbitrary cut-off value bears a high risk of excluding patients 13 
with heavier disease burden. Moreover, several other studies have 14 
reported a considerable heterogeneity in advanced disease stages of both 15 
PD [14] and dementia [35-37].  16 
Third, a complete separation between motor impact and cognitive/ADL 17 
dysfunction impact on physical behavior is currently not possible. However, 18 
we did reduce possible confounding effects by statistically correcting for the 19 
UPDRS III motor score. 20 
It should also be noted that because of the abilities of current sensor 21 
technology and data analysis techniques, the presented output parameters 22 
cannot serve as absolute descriptions of daily physical behavior, but rather 23 
enable the comparison of group performances. 24 
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Strengths of our study are the inclusion and successful assessment of 1 
patients with later disease stages, as well as the use of modern wearable 2 
technology, which allowed us to evaluate a comprehensive and detailed 3 
range of physical behavior outcomes. 4 
Results of this pilot study indicate that there are associations between the 5 
sedentary physical behavior pattern and ADL-impairment in PDD. This 6 
helps in identifying promising parameters that have the potential to improve 7 
the differentiation of PDD from both PD-NC and PD-MCI. To consolidate 8 
our findings, further studies with larger study samples, especially the PDD 9 
group, are necessary. Our results support the potential of objective physical 10 
behavior assessment in further understanding, screening, diagnosing, 11 
predicting, and monitoring cognitive impairment in PD. 12 
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Legend  
Figure 1 Overview of total time spent in different behaviors for the three study groups; PD-
NC, Parkinson’s disease with no cognitive impairment; PD-MCI, Parkinson’s disease 
with mild cognitive impairment; PDD, Parkinson’s disease dementia. Values were 
calculated using the ratio of each median with all summed medians of the study group. 
 
Figure 2 Comparisons of physical behavior parameters between the three study groups; 
PD-NC, Parkinson’s disease with no cognitive impairment; PD-MCI, Parkinson’s disease 
with mild cognitive impairment; PDD, Parkinson’s disease dementia. Data is presented 
with median and interquartile range. 
 
Figure 3 Comparisons of the physical behavior pattern between the three study groups: PD-
NC, Parkinson’s disease with no cognitive impairment; PD-MCI, Parkinson’s disease 
with mild cognitive impairment; PDD, Parkinson’s disease dementia. Data is presented 
with median and interquartile range. Statistically significant differences adjusted for 
depression (GDS) and motor impairment (UPDRS III) scores are presented with 
brackets, odds ratio (OR) with 95% confidence interval (CI) and p-values (P). 
Table 1 Characterization of the study sample. 
Variable Median (Minimum/Maximum) p-value 
 PD-NC (n=17) PD-MCI (n=22) PDD (n=9)  
Age 71 (44/80) 68 (57/78) 72 (67/75) 0.18 
Male gender, n (%) 10 (59%) 17 (77%) 9 (100%) 0.09 
Age of onset 64 (43/72) 61 (43/71) 65 (55/69) 0.43 
Disease duration (years) 6 (1/13) 6 (1/20) 6 (5/18) 0.11 
Hoehn & Yahr Stage, n (%)    
0.03 
1 6 (35%) 3 (14%) - 
2 10 (59%) 13 (59%) 3 (33%) 
3 1 (6%) 4 (18%) 3 (33%) 
4 - 2 (9%) 2 (22%) 
5 - - 1 (11%) 
UPDRS-III score 20 (11/58) 24 (10/62) 36 (14/56) 0.01 
LEDD 620 (160/2420) 763 (210/2378) 496 (100/1139) 0.16 
Geriatric Depression Scale (GDS) 2 (0/6) 5 (0/10) 8 (3/15) 0.001 
LEDD, Levodopa equivalence daily dose; n, number; PDD, Parkinson’s disease dementia; PD-MCI, 
Parkinson’s disease with mild cognitive impairment; PD-NC, Parkinson’s disease with no cognitive 
impairment; UPDRS-III, Unified Parkinson’s disease Rating Scale part III.
Table 2 Group comparisons adjusted for depression (GDS) and motor impairment (UPDRS-III) scores. 
 Median (Minimum/Maximum) PD-NC vs. PDD PD-MCI vs. PDD 
 PD-ND PD-MCI PDD p-value OR CI (95 %) p-value OR CI (95 %) 
Activity time [%] 
Time spent in activity (standing, shuffling, walking) 
0.21 (0.03/0.41) 0.21 (0.08/0.39) 0.09 (0.01/0.26) 0.22 3.05 0.50/18.53 0.28 2.35 0.50/10.99 
Activity intensity [g]  
 Mean intensity of activity 
0.08 (0.03/0.13) 0.07 (0.03/0.11) 0.07 (0.03/0.13) 0.89 1.13 0.19/6.72 0.56 0.63 0.14/2.93 
PAR of activity 
Relative EE to BMR of activity 
2.29 (1.35/3.13) 2.16 (1.43/2.87) 2.20 (1.39/3.08) 0.79 1.27 0.21/7.54 0.64 0.70 0.15/3.21 
Number of activity bouts  
Number of activity periods (=bouts) 
1555 (58/6385) 1470 (364/5011) 859 (49/2329) 0.32 2.48 0.41/14.90 0.37 2.01 0.43/9.38 
Mean activity bout length [s] 
Mean boutlength for performed activity bouts 
8.50 (0/41.24) 11.03 (6.06/23.91) 12.02 (7.22/19.84) 0.48 0.53 0.09/3.16 0.89 1.11 0.24/5.13 
Sedentary time [%] 
Time spent sedentary behavior (lying and sitting) 
0.75 (0.51/0.97) 0.78 (0.61/0.92) 0.89 (0.74/0.97) 0.10 0.21 0.03/1.33 0.14 0.31 0.07/1.48 
Sedentary intensity [g] 
Mean Intensity of sedentary behavior 
0.01 (0.01/0.04) 0.01 (0.01/0.04) 0.01 (0/0.04) 0.60 1.60 0.27/9.53 0.60 1.51 0.33/6.96 
PAR of sedentary 
Relative EE to BMR of sedentary behavior 
1.18 (1.14/1.66) 1.21 (1.12/1.58) 1.17 (1.13/1.64) 0.77 1.30 0.22/7.74 0.47 1.77 0.38/8.20 
Number of sedentary bouts 
Number of sedentary periods (=bouts) 
134 (63/219) 129 (43/711) 97 (22/159) 0.01 10.30 1.58/67.25 0.01 8.90 1.75/45.23 
Mean sedentary bout length [s] 
Mean boutlength for performed sedentary bouts 
506 (208/1344) 515 (83/1441) 727 (402/3869) 0.02 0.10 0.02/0.65 0.02 0.14 0.03/0.69 
Steps 
Number of steps performed per day 
5778 (43/14164) 4742 (167/10181) 2362 (15/13346) 0.48 1.91 0.32/11.42 0.72 1.33 0.29/6.11 
Total movement intensity [g] 
Mean Intensity of overall physical behavior 
0.03 (0.02/0.06) 0.03 (0.01/0.06) 0.03 (0.006/0.04) 0.76 1.32 0.22/7.82 0.90 0.90 0.20/4.16 
Sedentary activity [%] 
Time spent with intensity levels of ≤1.5 METs 
0.83 (0.60/0.93) 0.84 (0.67/0.96) 0.89 (0.56/0.98) 0.63 0.64 0.11/3.84 0.92 1.08 0.24/4.99 
Light activity [%] 
Time spent with intensity levels of 1.6 - 3.0 METs 
0.08 (0.02/0.33) 0.06 (0.02/0.24) 0.05 (0/0.41) 0.72 1.38 0.23/8.19 0.94 0.94 0.20/4.33 
Moderate activity [%] 
Time spent with intensity levels of 3.0-6.0 METs 
0.07 (0.02/0.15) 0.06 (0.01/0.13) 0.02 (0.0/0.07) 0.31 2.52 0.42/15.17 0.43 1.86 0.40/8.64 
Vigorous activity [%] 
Time spent with intensity levels of >=6.0METs 
0.0008 (0/0.03) 0.0007 (0/0.03) 0.0001 (0/0.04) 0.86 0.86 0.14/5.08 0.63 0.68 0.15/3.16 
AEE [MJ/d] 
Estimated EE during active behavior 
832 (514/1477) 775 (202/1081) 664 (314/1205) 0.71 1.41 0.24/8.39 0.76 0.79 0.17/3.63 
TEE [MJ/d] 
Estimated total EE 
2621 (1898/3500) 2572 (1127/3182) 2306 (1899/3186) 0.68 0.69 0.12/4.11 0.44 0.54 0.12/2.53 
PAL 
Relative EE to BMR of all behaviors 
1.47 (1.32/1.90) 1.48 (1.22/1.80) 1.44 (1.19/1.67) 0.75 1.33 0.22/7.91 0.81 1.20 0.26/5.54 
AEE, activity related energy expenditure; BMR, Basal Metabolic Rate; CI, Confidence Interval; EE, Energy Expenditure; GDS, Geriatric Depression Scale; MET, 
Mean equivalent of task; OR, Odds Ratio; PAL, physical activity level; PAR, physical activity ratio; PDD, Parkinson’s disease dementia; PD-MCI, Parkinson’s 
disease with mild cognitive impairment; PD-NC, Parkinson’s disease with no cognitive impairment; TEE, Total energy expenditure; UPDRS-III, Unified Parkinson 
Disease Rating Scale part III; P values < 0.05 are shown in bold.  



Table A Correlations between selected neuropsychological tests and physical behavior parameters 
**correlation level of significance P < .01; *correlation level of significance P < .05; PANDA, Parkinson Neuropsychometric Dementia Assessment ; MMSE, Minimental State 
Examination; CERAD, Consortium for the Registry for Alzheimer's Disease (CERAD); BTA, Brief test of attention; WMS, Wechsler Memory Scale Revised; mWCST, Modified Card 
Sorting Test; LPS 50+, intelligence scale Leistungsprüfsystem for subjects between 50 and 90 years of age; #Data referred to standardized scores (e.g. z-scores or percentile rank 
Test Function 
Activity 
time 
Activity 
intensity 
Number of 
activity 
bouts  
Mean 
activity 
bout 
length 
Sedentary 
time 
Sedentary 
intensity 
Number of 
sedentary 
bouts 
Mean 
sedentary 
bout 
length 
Steps Total 
movement 
intensity 
Sedentary 
activity 
Light 
activity 
Moderate 
activity 
Vigorous 
activity 
MMSE Global cognition -.07 .13 .09 -.17 .09 .09 .04 -.02 .08 .21 -.20 .11 .19 .15 
WMS-R: Digit Span forward# Working memory .16 .17 .16 -.11 -.10 -.09 .20 -.19 .26 -.05 .14 -.20 .18 .20 
WMS-R: Digit Span backward# Working memory -.06 .06 .01 -.10 .07 -.01 .07 -.05 .05 -.11 .11 -.07 -.06 -.02 
CERAD: Word-list recall# Verbal memory -.15 -.31* -.22 .14 .07 .15 -.18 .14 -.30* -.05 -.07 .13 -.17 -.26 
CERAD: Semantic fluency# Word generation .13 .01 .16 -.15 -.09 .20 .22 -.22 .05 .22 -.25 .22 .24 -.05 
CERAD: Phonematic fluency# Word generation -.26 -.20 -.20 -.01 .30* .15 -.25 .26 -.24 .01 -.12 .20 -.09 -.14 
Trail Making Test: Part A# Psychomotor speed -.22 .05 -.10 .01 .27 .15 -.20 .23 -.11 .12 -.18 .25 -.08 -.07 
Trail Making Test: Part B# Psychomotor speed/Set shifting .10 .23 .18 -.19 .00 .02 -.08 .08 .16 .23 -.14 .08 .29 .09 
Trail Making Test: A/B# Set shifting .29 .23 .30* -.28 -.19 -.14 -.02 -.03 .26 .09 .07 -.16 .31* .08 
CERAD: Praxis# Visuo-construction .20 .27 .23 -.15 -.13 -.30* .32* -.29 .25 -.12 .22 -.27 .20 .13 
LPS 50+ 7: Mental Rotation# Visuo-construction .28 .29 .31* -.19 -.22 -.08 .09 -.13 .32* .26 -.17 .02 .47** .29 
LPS 50+ 9: Spatial Sense# Visuo-construction .13 .18 .21 -.30* -.02 .23 .11 -.10 .20 .35* -.36* .30* .31* .14 
Stroop: Word naming Directed attention .11 .24 .24 -.34* -.03 .12 .11 -.13 .16 .30* -.24 .17 .34* .06 
Stroop: Color naming Directed attention .18 .24 .28 -.34* -.12 .21 .19 -.23 .16 .34* -.33* .26 .34* .07 
Stroop: Interference condition Inhibition .02 .17 .15 -.20 .04 .16 .06 -.07 .06 .24 -.22 .18 .23 .03 
scores, indicating the patient’s relative position in the norm group with a range between 0 and 100) of healthy German control subjects as published in the manuals. Data are 
corrected either for age or for age and education (CERAD, TMT, mWCST). 
 
Figure A Correlations between physical behavior parameters. 
 
Spearman´s coefficient for the parameter outcomes of Time (A), Movement Intensity (B), Number of Bouts (C) and Mean Bout length (D) between different behaviors over all study groups. **correlation 
level of significance P < 0.01, *correlation level of significance P < 0.05. 
